Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Description

To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.

Conditions

Dyspnea

Study Overview

Study Details

Study overview

To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Condition
Dyspnea
Intervention / Treatment

-

Contacts and Locations

Houston

MD Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of advanced cancer (metastatic, locally advanced, recurrent, or incurable).
  • * Age 18 or older.
  • * Admitted to a medical floor.
  • * Dyspnea intensity at rest of at least 4 on a 0-10-point NRS (where 0 = none, 10 = worst).
  • * Speak English or Spanish.
  • * Hemodynamic instability requiring active Merit Team or ICU team involvement.
  • * Delirium as per clinical team's assessment in the Electronic Health Record (EHR).
  • * Severe hypoxemia (SpO2 \< 90% despite supplemental oxygen of up to 6 L/min).
  • * Continuous positive airway pressure (CPAP) use for obstructive sleep apnea \>10 hours a day.
  • * Respiratory failure necessitating mechanical ventilation (i.e., HFNC or NIV), and planned thoracentesis within 72 hours of enrollment.
  • * Patients with known pregnancy.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

David Hui, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2032-03-31